Drug Pipeline

Pridopidine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
3
Phase 3
2
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-10 NCT07322003
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS		 Trial sites expanded: 5 -> 16 locations
2026-06-05 NCT04297683
HEALEY ALS Platform Trial - Master Protocol		 Trial sites expanded: 78 -> 81 locations
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-27 NCT07609108 Pridopidine Phase 3 Study in Huntington's Disease Phase 3 Not Yet Recruiting
Active Studies by Phase
Phase 3
2
Phase 2/3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07322003 Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS Amyotrophic Lateral Sclerosis Recruiting
NCT07609108 Pridopidine Phase 3 Study in Huntington's Disease Huntington Disease Not Yet Recruiting
Phase 2/3
NCT04297683 HEALEY ALS Platform Trial - Master Protocol Amyotrophic Lateral Sclerosis Recruiting
Sponsors Running Pridopidine Trials
Prilenia (2) Merit E. Cudkowicz, MD (1)
Disease Areas
ALS (2) Huntington's Disease (1)
Get alerts when Pridopidine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free